Phaarmasia Ltd. is significantly underperforming compared to its peers in the Pharmaceuticals & Drugs industry, showing zero growth in revenue and profitability metrics. The company has a negative PE ratio and lacks efficiency indicators such as ROE and ROA, making it a concerning investment in the current market landscape.

• • Phaarmasia Ltd. has zero revenue growth and negative EPS
• • It exhibits no profitability or efficiency metrics compared to peers
• • Financial indicators suggest it is a high-risk investment with no returns